Wipro GE Healthcare Private recalls

3 official recalls and safety alerts involving Wipro GE Healthcare Private since 2024-02, from FDA · Device. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Wipro GE Healthcare Private or the relevant agency.

  1. 2025-10-29
  2. US
    Drugs & medicalClass II

    Wipro GE Healthcare Private Ltd. recalls GE Healthcare Carescape Central Station (CSCS) V3 MAS800 Desktop with software version V3.0.5, Part Number 5867474-03; Medical…

    Carescape Central Station (CSCS), software version V3.0.5, can cause the system to enter a continuous reboot cycle. If this occurs, a loss of central monitoring of connected patients could result. This issue occurs…

    FDA · DeviceWipro GE Healthcare Private Ltd.Worldwide distribution.Official notice →
  3. 2024-10-02
  4. US
    Drugs & medicalClass II

    Wipro GE Healthcare Private Ltd. recalls GE Panda iRES Warmer, Model/Catalog Numbers: 1) M1112198-01045518; 2) M1112198-01045579; 3) M1112198-01047148; 4)…

    GE HealthCare has become aware that complete electrical safety testing was not conducted during manufacturing of certain Giraffe and Panda iRes Warmers. There are multiple electrical safety protections included in the…

    FDA · DeviceWipro GE Healthcare Private Ltd.US and Australia, Denmark, France, Germany, Ireland, ITALY, New Zealand,…Official notice →
  5. 2024-02-21
  6. US
    Drugs & medicalClass I

    Wipro GE Healthcare Private Ltd. recalls GE Healthcare neonatal incubator, models: a) Care Plus, b) Care Plus 1000, c) Care Plus 2000, d) Care Plus 3000, e) Care Plus…

    GE HealthCare has become aware that the bedside panel of Care Plus, Care Plus¿ Model 1000, 2000, 3000 and 4000 Incubator, Lullaby Incubator, Lullaby TR Incubator, and Lullaby XP Incubator can be upright and look closed…

    FDA · DeviceWipro GE Healthcare Private Ltd.Worldwide distribution.Official notice →